The physician - who lives in Upper Manhattan - had returned to NYC ten days ago after treating Ebola patients in West Africa. Late in the trading session today, stocks gave back some of their big gains on a report he had been hospitalized with Ebola-type symptoms.
City officials are at work tracing the doctor's contacts to determine who else may be at risk, and his girlfriend is being tested for the disease.
Nano cap (NYSEMKT:IBIO) is up 52% premaket on robust volume in apparent response to its press release about the applicability of its iBioLaunch technology to the development of antibodies that target Ebola. Over zealous traders appear to be ignoring the long-term nature of the applicability.
As previously reported,the company licensed iBioLaunch to would-be ZMapp manufacturer Caliber Biotherapeutics.
: Maybe a AH of $15 is possible on ST, LAKE and APT did a AH too..
Oct 15, 5:40 PM
VSR vs. ETF Alternatives
Versar Inc together with its subsidiaries provides solutions to government and commercial clients relating construction management, environmental services, munitions response, telecommunications, and energy in the United States.